171 related articles for article (PubMed ID: 37610040)
1. Intracranial granuloma in a patient with granulomatosis with polyangiitis under rituximab maintenance: A case report.
Ince B; Eroğlu E; Barburoğlu M; Yalçinkaya Y; Artim-Esen B; Gül A; Inanç M
Int J Rheum Dis; 2024 Jan; 27(1):e14887. PubMed ID: 37610040
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series.
Knight A; Hallenberg H; Baecklund E
Clin Rheumatol; 2014 Jun; 33(6):841-8. PubMed ID: 23959445
[TBL] [Abstract][Full Text] [Related]
4. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
[TBL] [Abstract][Full Text] [Related]
5. Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitis.
Sorin B; Samson M; Durel CA; Diot E; Guichard I; Grados A; Limal N; Régent A; Cohen P; Dion J; Legendre P; Le Guern V; Mouthon L; Guillevin L; Terrier B;
Rheumatology (Oxford); 2022 May; 61(6):2619-2624. PubMed ID: 34698818
[TBL] [Abstract][Full Text] [Related]
6. How best to manage relapse and remission in ANCA-associated vasculitis.
Puéchal X; Guillevin L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
8. [A case of PR3-ANCA positive granulomatosis with polyangiitis recurrent with acute kidney injury after 7 years remission].
Kawamoto S; Koda R; Yoshino A; Takeda T; Ueda Y
Nihon Jinzo Gakkai Shi; 2014; 56(7):1097-103. PubMed ID: 25420411
[TBL] [Abstract][Full Text] [Related]
9. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
10. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
11. Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohort.
Chasseur P; Blockmans D; von Frenckell C; Nicolas JB; Regniers C; Vandergheynst F
Acta Clin Belg; 2020 Jun; 75(3):163-169. PubMed ID: 30767717
[No Abstract] [Full Text] [Related]
12. Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomes.
Sorin B; Iudici M; Guerry MJ; Samson M; Bielefeld P; Maillet T; Nouvier M; Karras A; Meyer L; Lavigne C; Régent A; Durel CA; Fabre M; Charles P; Raimbourg Q; Lanteri A; Pugnet G; Rivière F; Pineton de Chambrun M; Cacoub P; Le Guenno G; Jourdain P; Mekinian A; Paule R; Dion J; Legendre P; Cohen P; Guillevin L; Puéchal X; Terrier B
Rheumatology (Oxford); 2023 Nov; 62(11):3662-3671. PubMed ID: 36847447
[TBL] [Abstract][Full Text] [Related]
13. Uncommon presentation of granulomatosis with polyangiitis: Prostate involvement.
Jain N; Roy D; Mysore S; Negigowdru MM; Rao VKR
Int J Rheum Dis; 2024 Jan; 27(1):e14831. PubMed ID: 37424167
[TBL] [Abstract][Full Text] [Related]
14. Novel Therapies for ANCA-associated Vasculitis.
Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies.
Ayan G; Esatoglu SN; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Fresko I; Ozdogan H; Yurdakul S; Hamuryudan V
Rheumatol Int; 2018 Apr; 38(4):607-622. PubMed ID: 29322343
[TBL] [Abstract][Full Text] [Related]
16. Prolonged B cell depletion with rituximab is effective in treating refractory pulmonary granulomatous inflammation in granulomatosis with polyangiitis (GPA).
Henderson SR; Copley SJ; Pusey CD; Ind PW; Salama AD
Medicine (Baltimore); 2014 Dec; 93(27):e229. PubMed ID: 25501085
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.
Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
Intern Med; 2018 Aug; 57(15):2247-2250. PubMed ID: 29526948
[TBL] [Abstract][Full Text] [Related]
18. Predicting factors for relapse in patients with granulomatosis with polyangiitis: results from a long-term cohort.
Mehrabi Nejad MM; Jazayeri SB; Ayoobi Yazdi N; Afshar A; Alesaeidi S
Clin Rheumatol; 2022 Aug; 41(8):2457-2465. PubMed ID: 35397719
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
